U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    SDC4 syndecan 4 [ Homo sapiens (human) ]

    Gene ID: 6385, updated on 27-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Association between syndecan-4 and subclinical atherosclerosis in ankylosing spondylitis.

    Association between syndecan-4 and subclinical atherosclerosis in ankylosing spondylitis.
    Sertdemir AL, Şahin AT, Duran M, Çelik M, Tatar S, Oktay İ, Alsancak Y., Free PMC Article

    02/1/2024
    Insufficient Syndecan-4 is associated with chronic lung disease development in preterm infants.

    Insufficient Syndecan-4 is associated with chronic lung disease development in preterm infants.
    Matsuzaki Y, Wang X, Tanino Y, Ikeda K.

    01/4/2024
    Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival.

    Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival.
    Poças J, Marques C, Gomes C, Otake AH, Pinto F, Ferreira M, Silva T, Faria-Ramos I, Matos R, Ribeiro AR, Senra E, Cavadas B, Batista S, Maia J, Macedo JA, Lima L, Afonso LP, Ferreira JA, Santos LL, Polónia A, Osório H, Belting M, Reis CA, Costa-Silva B, Magalhães A., Free PMC Article

    05/12/2023
    Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9.

    Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9.
    Hudák A, Roach M, Pusztai D, Pettkó-Szandtner A, Letoha A, Szilák L, Azzouz M, Letoha T., Free PMC Article

    02/28/2023
    High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma.

    High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma.
    Zhu Y, Zheng D, Lei L, Cai K, Xie H, Zheng J, Yu C., Free PMC Article

    10/15/2022
    Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression.

    Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression.
    Beauvais DM, Nelson SE, Adams KM, Stueven NA, Jung O, Rapraeger AC., Free PMC Article

    07/2/2022
    Syndecan-4 is correlated with disease activity and serological characteristic of rheumatoid arthritis.

    Syndecan-4 is correlated with disease activity and serological characteristic of rheumatoid arthritis.
    Zhao J, Ye X, Zhang Z.

    06/25/2022
    Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers.

    Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers.
    Pham SH, Pratt K, Okolicsanyi RK, Oikari LE, Yu C, Peall IW, Arif KT, Chalmers TA, Gyimesi M, Griffiths LR, Haupt LM.

    06/25/2022
    The effects of YKL-40 on angiogenic potential of HUVECs are partly mediated by syndecan-4.

    The effects of YKL-40 on angiogenic potential of HUVECs are partly mediated by syndecan-4.
    Sun W, Xue Q, Zhao Y, Zheng J., Free PMC Article

    03/12/2022
    microRNA-140-3p modulates invasiveness, motility, and extracellular matrix adhesion of breast cancer cells by targeting syndecan-4.

    microRNA-140-3p modulates invasiveness, motility, and extracellular matrix adhesion of breast cancer cells by targeting syndecan-4.
    Onyeisi JOS, Greve B, Espinoza-Sánchez NA, Kiesel L, Lopes CC, Götte M.

    02/19/2022
    Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant's Superior Transmission.

    Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant's Superior Transmission.
    Hudák A, Veres G, Letoha A, Szilák L, Letoha T., Free PMC Article

    01/29/2022
    MMP-9 mediated Syndecan-4 shedding correlates with osteoarthritis severity.

    MMP-9 mediated Syndecan-4 shedding correlates with osteoarthritis severity.
    Bollmann M, Pinno K, Ehnold LI, Märtens N, Märtson A, Pap T, Stärke C, Lohmann CH, Bertrand J.

    12/25/2021
    Mesoglycan connects Syndecan-4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro.

    Mesoglycan connects Syndecan-4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro.
    Pessolano E, Belvedere R, Novizio N, Filippelli A, Perretti M, Whiteford J, Petrella A., Free PMC Article

    12/4/2021
    Diagnostic value of syndecan-4 protein expression in colorectal cancer.

    Diagnostic value of syndecan-4 protein expression in colorectal cancer.
    Jechorek D, Haeusler-Pliske I, Meyer F, Roessner A.

    12/4/2021
    Serum syndecan-4 is associated with nonalcoholic fatty liver disease.

    Serum syndecan-4 is associated with nonalcoholic fatty liver disease.
    Xia SJ, Tang LZ, Li WH, Xu ZS, Zhang LL, Cheng FG, Chen HX, Wang ZH, Luo YC, Dai AN, Fan JG.

    10/23/2021
    Syndecan Family Gene and Protein Expression and Their Prognostic Values for Prostate Cancer.

    Syndecan Family Gene and Protein Expression and Their Prognostic Values for Prostate Cancer.
    Santos NJ, Barquilha CN, Barbosa IC, Macedo RT, Lima FO, Justulin LA, Barbosa GO, Carvalho HF, Felisbino SL., Free PMC Article

    09/18/2021
    ADAMTS-1 and syndecan-4 intersect in the regulation of cell migration and angiogenesis.

    ADAMTS-1 and syndecan-4 intersect in the regulation of cell migration and angiogenesis.
    Lambert J, Makin K, Akbareian S, Johnson R, Alghamdi AAA, Robinson SD, Edwards DR., Free PMC Article

    07/31/2021
    [Change of serum levels of pentraxin-3 and syndecan-4 in children with chronic heart failure].

    [Change of serum levels of pentraxin-3 and syndecan-4 in children with chronic heart failure].
    Zhang FH, Zhao XL, Feng S, An JD., Free PMC Article

    07/10/2021
    Principal mode of Syndecan-4 mechanotransduction for the endothelial glycocalyx is a scissor-like dimer motion.

    Principal mode of Syndecan-4 mechanotransduction for the endothelial glycocalyx is a scissor-like dimer motion.
    Jiang XZ, Luo KH, Ventikos Y.

    07/3/2021
    Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancer.

    Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancer.
    Kim S, Han Y, Kim SI, Lee J, Jo H, Wang W, Cho U, Park WY, Rando TA, Dhanasekaran DN, Song YS., Free PMC Article

    06/19/2021
    Syndecan-4 is regulated by IL-1beta in beta-cells and human islets.

    Syndecan-4 is regulated by IL-1β in β-cells and human islets.
    Brioudes E, Alibashe-Ahmed M, Lavallard V, Berney T, Bosco D.

    05/29/2021
    Syndecan-4 tunes cell mechanics by activating the kindlin-integrin-RhoA pathway.

    Syndecan-4 tunes cell mechanics by activating the kindlin-integrin-RhoA pathway.
    Chronopoulos A, Thorpe SD, Cortes E, Lachowski D, Rice AJ, Mykuliak VV, Róg T, Lee DA, Hytönen VP, Del Río Hernández AE., Free PMC Article

    11/28/2020
    Syndecan-4 involves in the pathogenesis of rheumatoid arthritis by regulating the inflammatory response and apoptosis of fibroblast-like synoviocytes.

    Syndecan-4 involves in the pathogenesis of rheumatoid arthritis by regulating the inflammatory response and apoptosis of fibroblast-like synoviocytes.
    Cai P, Lu Z, Jiang T, Wang Z, Yang Y, Zheng L, Zhao J.

    10/24/2020
    Direct interactions between ALIX, syntenin and syndecan-4 are essential for proper enrichment of the ESCRT-III machinery at the cytokinetic abscission site.

    The Flemmingsome reveals an ESCRT-to-membrane coupling via ALIX/syntenin/syndecan-4 required for completion of cytokinesis.
    Addi C, Presle A, Frémont S, Cuvelier F, Rocancourt M, Milin F, Schmutz S, Chamot-Rooke J, Douché T, Duchateau M, Giai Gianetto Q, Salles A, Ménager H, Matondo M, Zimmermann P, Gupta-Rossi N, Echard A., Free PMC Article

    08/1/2020
    By triggering the syndecan-4/PKCalpha pathway.

    Mesoglycan induces keratinocyte activation by triggering syndecan-4 pathway and the formation of the annexin A1/S100A11 complex.
    Bizzarro V, Belvedere R, Pessolano E, Parente L, Petrella F, Perretti M, Petrella A.

    05/30/2020
    firstprevious page of 5 nextlast